Scientific rationale and study design of the individualized dosing efficacy vs flat dosing to assess optimal pegylated interferon therapy (IDEAL) trial: determining optimal dosing in patients with genotype 1 chronic hepatitis C
Year: 2008
Type: article
Study design: Study Protocol
Source: Journal of Viral Hepatitis
Authors: J. McHutchison, M. Sulkowski
Institutions: Duke University, Duke Medical Center, Johns Hopkins University
Language: English
Topic: Hepatitis C virus research
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W1990551665